3 Reasons to Buy Nvidia in the Fall

Nvidia is guiding for $108 billion of current-quarter revenue, up 89% year over year, after fiscal Q2 revenue growth accelerated to 106%. Wall Street EPS estimates have risen to $9.31 for fiscal 2027 and $15.68 for the following year, increases of 43% and 85% from prior expectations, leaving the shares at roughly 14x next-year earnings despite a 19% gain in 2026. Potential reopening of China data-center chip sales represents incremental upside, though export restrictions remain in place and the article flags risks around AI infrastructure opposition, safety concerns, and elevated 75% gross and 56% net margins.

Analysis

The key investment question is not whether demand remains strong, but whether NVDA can convert backlog into earnings without a mix-driven margin reset. Incremental China access would initially be less additive than headline revenue suggests if advanced packaging, HBM, and networking remain supply-constrained: shipments could displace higher-margin hyperscaler allocations. The larger 6-18 month benefit is utilization of lower-spec export-compliant products and an expanded installed base, while the near-term beneficiary of renewed China competition could be AMD only if licensing rules permit it to sell products with a materially better performance-per-dollar position.

Consensus is likely underweighting the capex return hurdle. Hyperscalers can sustain procurement through the next two quarters, but 2027 estimates require AI revenue monetization to broaden beyond cloud leasing and internal productivity projects; otherwise, buyers will pivot toward custom ASICs and lower-cost inference alternatives. That creates downside asymmetry for NVDA's gross-margin expectations even if revenue continues to grow, with Marvell (MRVL), Broadcom (AVGO), and AMD the principal listed substitution beneficiaries over 6-18 months.

Near-term catalyst is the November result and, more importantly, evidence that customer concentration, networking attach rates, and Blackwell/next-platform supply are supporting the forward gross-margin guide. A China policy headline can drive days-to-weeks upside, but should be treated as an option rather than base-case earnings until export licenses and permitted configuration are documented. Falsify the constructive view if forward gross margin falls below ~72%, large customer capex guidance is cut, or management signals that supply availability—not demand—is no longer the binding constraint.

Key Decisions for Investors

• Maintain a core long NVDA into November only at a reduced risk budget; add after results if forward revenue guidance and gross-margin trajectory validate estimates. Target 15-20% upside over 3 months versus 12-15% downside if margin guidance resets; use a stop/review trigger on a sub-72% forward gross-margin outlook.
• Express the policy optionality with a defined-risk NVDA call spread expiring after the November earnings release rather than adding outright exposure on diplomatic headlines. China-license verification is the required trigger; absent that, the premium is vulnerable to post-event volatility compression.
• Initiate a 6-12 month relative-value basket: long AVGO and MRVL versus short a smaller notional NVDA position if custom-silicon wins or hyperscaler ASIC commentary accelerates. The trade is invalidated by NVDA maintaining both premium pricing and stable gross margins while customer capex remains broad-based.
• Monitor MU and SK Hynix supply/price indicators as a second-order read-through. Tight HBM pricing supports the AI complex near term, but a sharp easing in memory lead times would signal accelerator supply normalization and reduce NVDA's scarcity premium before revenue growth visibly slows.